Literature DB >> 24193343

Recessive myosin myopathy with external ophthalmoplegia associated with MYH2 mutations.

Homa Tajsharghi1, Simon Hammans2, Christopher Lindberg3, Alexander Lossos4, Nigel F Clarke5, Ingrid Mazanti6, Leigh B Waddell5, Yakov Fellig7, Nicola Foulds8, Haider Katifi2, Richard Webster9, Olayinka Raheem10, Bjarne Udd11, Zohar Argov4, Anders Oldfors1.   

Abstract

Myosin myopathies comprise a group of inherited diseases caused by mutations in myosin heavy chain (MyHC) genes. Homozygous or compound heterozygous truncating MYH2 mutations have been demonstrated to cause recessive myopathy with ophthalmoplegia, mild-to-moderate muscle weakness and complete lack of type 2A muscle fibers. In this study, we describe for the first time the clinical and morphological characteristics of recessive myosin IIa myopathy associated with MYH2 missense mutations. Seven patients of five different families with a myopathy characterized by ophthalmoplegia and mild-to-moderate muscle weakness were investigated. Muscle biopsy was performed to study morphological changes and MyHC isoform expression. Five of the patients were homozygous for MYH2 missense mutations, one patient was compound heterozygous for a missense and a nonsense mutation and one patient was homozygous for a frame-shift MYH2 mutation. Muscle biopsy demonstrated small or absent type 2A muscle fibers and reduced or absent expression of the corresponding MyHC IIa transcript and protein. We conclude that mild muscle weakness and ophthalmoplegia in combination with muscle biopsy demonstrating small or absent type 2A muscle fibers are the hallmark of recessive myopathy associated with MYH2 mutations.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24193343      PMCID: PMC4023224          DOI: 10.1038/ejhg.2013.250

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  35 in total

1.  Expression and DNA sequence analysis of a human embryonic skeletal muscle myosin heavy chain gene.

Authors:  I Karsch-Mizrachi; M Travis; H Blau; L A Leinwand
Journal:  Nucleic Acids Res       Date:  1989-08-11       Impact factor: 16.971

2.  Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy.

Authors:  Pascale Richard; Philippe Charron; Lucie Carrier; Céline Ledeuil; Theary Cheav; Claire Pichereau; Abdelaziz Benaiche; Richard Isnard; Olivier Dubourg; Marc Burban; Jean-Pierre Gueffet; Alain Millaire; Michel Desnos; Ketty Schwartz; Bernard Hainque; Michel Komajda
Journal:  Circulation       Date:  2003-04-21       Impact factor: 29.690

Review 3.  The mammalian myosin heavy chain gene family.

Authors:  A Weiss; L A Leinwand
Journal:  Annu Rev Cell Dev Biol       Date:  1996       Impact factor: 13.827

4.  Mutations of the beta myosin heavy chain gene in hypertrophic cardiomyopathy: critical functional sites determine prognosis.

Authors:  A Woo; H Rakowski; J C Liew; M-S Zhao; C-C Liew; T G Parker; M Zeller; E D Wigle; M J Sole
Journal:  Heart       Date:  2003-10       Impact factor: 5.994

5.  Type IIx myosin heavy chain transcripts are expressed in type IIb fibers of human skeletal muscle.

Authors:  V Smerdu; I Karsch-Mizrachi; M Campione; L Leinwand; S Schiaffino
Journal:  Am J Physiol       Date:  1994-12

6.  Mutations in the slow skeletal muscle fiber myosin heavy chain gene (MYH7) cause laing early-onset distal myopathy (MPD1).

Authors:  Christopher Meredith; Ralf Herrmann; Cheryl Parry; Khema Liyanage; Danielle E Dye; Hayley J Durling; Rachael M Duff; Kaye Beckman; Marianne de Visser; Maaike M van der Graaff; Peter Hedera; John K Fink; Elizabeth M Petty; Phillipa Lamont; Vicki Fabian; Leslie Bridges; Thomas Voit; Frank L Mastaglia; Nigel G Laing
Journal:  Am J Hum Genet       Date:  2004-08-20       Impact factor: 11.025

7.  Comprehensive analysis of the beta-myosin heavy chain gene in 389 unrelated patients with hypertrophic cardiomyopathy.

Authors:  Sara L Van Driest; Michele A Jaeger; Steve R Ommen; Melissa L Will; Bernard J Gersh; A Jamil Tajik; Michael J Ackerman
Journal:  J Am Coll Cardiol       Date:  2004-08-04       Impact factor: 24.094

8.  Three-dimensional structure of myosin subfragment-1: a molecular motor.

Authors:  I Rayment; W R Rypniewski; K Schmidt-Bäse; R Smith; D R Tomchick; M M Benning; D A Winkelmann; G Wesenberg; H M Holden
Journal:  Science       Date:  1993-07-02       Impact factor: 47.728

9.  Autosomal dominant distal myopathy: linkage to chromosome 14.

Authors:  N G Laing; B A Laing; C Meredith; S D Wilton; P Robbins; K Honeyman; S Dorosz; H Kozman; F L Mastaglia; B A Kakulas
Journal:  Am J Hum Genet       Date:  1995-02       Impact factor: 11.025

10.  Molecular genetic characterization of a developmentally regulated human perinatal myosin heavy chain.

Authors:  R Feghali; L A Leinwand
Journal:  J Cell Biol       Date:  1989-05       Impact factor: 10.539

View more
  14 in total

1.  RYR1 and CACNA1S genetic variants identified with statin-associated muscle symptoms.

Authors:  Paul J Isackson; Jianxin Wang; Mohammad Zia; Paul Spurgeon; Adrian Levesque; Jonathan Bard; Smitha James; Norma Nowak; Tae Keun Lee; Georgirene D Vladutiu
Journal:  Pharmacogenomics       Date:  2018-10-16       Impact factor: 2.533

2.  Defective sarcomere organization and reduced larval locomotion and fish survival in slow muscle heavy chain 1 (smyhc1) mutants.

Authors:  Siping Li; Haishen Wen; Shaojun Du
Journal:  FASEB J       Date:  2019-12-01       Impact factor: 5.191

3.  A novel MYH2 mutation in family members presenting with congenital myopathy, ophthalmoplegia and facial weakness.

Authors:  Tracey Willis; Carola Hedberg-Oldfors; Zoya Alhaswani; Richa Kulshrestha; Caroline Sewry; Anders Oldfors
Journal:  J Neurol       Date:  2016-05-13       Impact factor: 4.849

4.  Single-nucleus cross-tissue molecular reference maps toward understanding disease gene function.

Authors:  Gökcen Eraslan; Eugene Drokhlyansky; Shankara Anand; Evgenij Fiskin; Ayshwarya Subramanian; Michal Slyper; Jiali Wang; Ayellet V Segrè; François Aguet; Orit Rozenblatt-Rosen; Kristin G Ardlie; Aviv Regev; Nicholas Van Wittenberghe; John M Rouhana; Julia Waldman; Orr Ashenberg; Monkol Lek; Danielle Dionne; Thet Su Win; Michael S Cuoco; Olena Kuksenko; Alexander M Tsankov; Philip A Branton; Jamie L Marshall; Anna Greka; Gad Getz
Journal:  Science       Date:  2022-05-13       Impact factor: 63.714

Review 5.  Skeletal muscle fiber type: using insights from muscle developmental biology to dissect targets for susceptibility and resistance to muscle disease.

Authors:  Jared Talbot; Lisa Maves
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2016-05-19       Impact factor: 5.814

6.  Homozygous recessive MYH2 mutation mimicking dominant MYH2 associated myopathy.

Authors:  Andrew R Findlay; Matthew B Harms; Alan Pestronk; Conrad C Weihl
Journal:  Neuromuscul Disord       Date:  2018-05-21       Impact factor: 4.296

7.  Bi-allelic mutations in MYL1 cause a severe congenital myopathy.

Authors:  Gianina Ravenscroft; Irina T Zaharieva; Carlo A Bortolotti; Matteo Lambrughi; Marcello Pignataro; Marco Borsari; Caroline A Sewry; Rahul Phadke; Goknur Haliloglu; Royston Ong; Hayley Goullée; Tamieka Whyte; Uk K Consortium; Adnan Manzur; Beril Talim; Ulkuhan Kaya; Daniel P S Osborn; Alistair R R Forrest; Nigel G Laing; Francesco Muntoni
Journal:  Hum Mol Genet       Date:  2018-12-15       Impact factor: 6.150

8.  Enhancement of myogenic differentiation and inhibition of rhabdomyosarcoma progression by miR-28-3p and miR-193a-5p regulated by SNAIL.

Authors:  Klaudia Skrzypek; Artur Nieszporek; Bogna Badyra; Małgorzata Lasota; Marcin Majka
Journal:  Mol Ther Nucleic Acids       Date:  2021-04-20       Impact factor: 8.886

9.  Epidemiology of muscular dystrophies in the Mediterranean area.

Authors:  Haluk Topaloglu
Journal:  Acta Myol       Date:  2013-12

10.  Developmental MYH3 Myopathy Associated with Expression of Mutant Protein and Reduced Expression Levels of Embryonic MyHC.

Authors:  Malgorzata Pokrzywa; Michaela Norum; Johan Lengqvist; Mehrnaz Ghobadpour; Saba Abdul-Hussein; Ali-Reza Moslemi; Homa Tajsharghi
Journal:  PLoS One       Date:  2015-11-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.